1. Preface
1.1. Report Scope and Market Segmentation
1.2. Research Highlights
2. Assumptions and Research Methodology
2.1. Assumptions and Acronyms Used
2.2. Research Methodology
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Dynamics
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunity
4.3. Global Newborn Screening Market Forecast
4.4. Global Newborn Screening Market Outlook
5. Market Outlook
5.1. Key Industry Events (mergers, acquisitions, partnerships, collaborations, etc.)
5.2. COVID-19 Pandemic Impact on Industry (value chain and short / mid / long term impact)
5.3. Overview of the Neonatal Research Funding/Grants
6. Global Newborn Screening Market Analysis, by Product
6.1. Introduction
6.2. Global Newborn Screening Market Value Share and Attractiveness Analysis, by Product
6.3. Global Newborn Screening Market Forecast, by Product
6.3.1. Instruments
6.3.1.1. Tabletop
6.3.1.2. Point-of-Care Testing
6.3.2. Assay Kits
6.4. Global Newborn Screening Market Analysis, by Product
7. Global Newborn Screening Market Analysis, by Test Type
7.1. Introduction
7.2. Global Newborn Screening Market Value Share and Attractiveness Analysis, by Test Type
7.3. Global Newborn Screening Market Forecast, by Test Type
7.3.1. Dry Blood Spot Test
7.3.2. Hearing Screen Test
7.3.3. Critical Congenital Heart Disease (CCHD) Test
7.3.4. X-ray or CT Scan
7.3.5. Electrocardiogram (ECG) Test
7.3.6. Others
7.4. Global Newborn Screening Market Analysis, by Test Type
8. Global Newborn Screening Market Analysis, by End-user
8.1. Introduction
8.2. Global Newborn Screening Market Value Share and Attractiveness Analysis, by End-user
8.3. Global Newborn Screening Market Forecast, by End-user
8.3.1. Hospitals
8.3.2. Diagnostic Centers
8.3.3. Maternity & Specialty Clinics
8.3.4. Others
8.4. Global Newborn Screening Market Analysis, by End-user
9. Global Newborn Screening Market Analysis, by Region
9.1. Global Newborn Screening Market Scenario, by Region/Country
9.2. Global Newborn Screening Market Value Share and Attractiveness Analysis, by Region
9.3. Global Newborn Screening Market Forecast, by Region
9.3.1. North America
9.3.2. Europe
9.3.3. Asia Pacific
9.3.4. Latin America
9.3.5. Middle East & Africa
10. North America Newborn Screening Market Analysis
10.1. North America Newborn Screening Market Overview
10.2. North America Newborn Screening Market Value Share and Attractiveness Analysis, by Country
10.3. North America Newborn Screening Market Forecast, by Country
10.3.1. U.S.
10.3.2. Canada
10.4. North America Newborn Screening Market Value Share and Attractiveness Analysis, by Product
10.5. North America Newborn Screening Market Forecast, by Product
10.5.1. Instruments
10.5.1.1. Tabletop
10.5.1.2. Point-of-Care Testing
10.5.2. Assay Kits
10.6. North America Newborn Screening Market Value Share and Attractiveness Analysis, by Test Type
10.7. North America Newborn Screening Market Forecast, by Test Type
10.7.1. Dry Blood Spot Test
10.7.2. Hearing Screen Test
10.7.3. Critical Congenital Heart Disease (CCHD) Test
10.7.4. X-ray or CT Scan
10.7.5. Electrocardiogram (ECG) Test
10.7.6. Others
10.8. North America Newborn Screening Market Value Share and Attractiveness Analysis, by End-user
10.9. North America Newborn Screening Market Forecast, by End-user
10.9.1. Hospitals
10.9.2. Diagnostic Centers
10.9.3. Maternity & Specialty Clinics
10.9.4. Others
11. Europe Newborn Screening Market Analysis
11.1. Europe Newborn Screening Market Overview
11.2. Europe Newborn Screening Market Value Share and Attractiveness Analysis, by Country/Sub-region
11.3. Europe Newborn Screening Market Forecast, by Country/Sub-region
11.3.1. Germany
11.3.2. France
11.3.3. U.K.
11.3.4. Italy
11.3.5. Spain
11.3.6. Rest of Europe
11.4. Europe Newborn Screening Market Value Share and Attractiveness Analysis, by Product
11.5. Europe Newborn Screening Market Forecast, by Product
11.5.1. Instruments
11.5.1.1. Tabletop
11.5.1.2. Point-of-Care Testing
11.5.2. Assay Kits
11.6. Europe Newborn Screening Market Value Share and Attractiveness Analysis, by Test Type
11.7. Europe Newborn Screening Market Forecast, by Test Type
11.7.1. Dry Blood Spot Test
11.7.2. Hearing Screen Test
11.7.3. Critical Congenital Heart Disease (CCHD) Test
11.7.4. X-ray or CT Scan
11.7.5. Electrocardiogram (ECG) Test
11.7.6. Others
11.8. Europe Newborn Screening Market Value Share and Attractiveness Analysis, by End-user
11.9. Europe Newborn Screening Market Forecast, by End-user
11.9.1. Hospitals
11.9.2. Diagnostic Centers
11.9.3. Maternity & Specialty Clinics
11.9.4. Others
12. Asia Pacific Newborn Screening Market Analysis
12.1. Asia Pacific Newborn Screening Market Overview
12.2. Asia Pacific Newborn Screening Market Value Share and Attractiveness Analysis, by Country/Sub-region
12.3. Asia Pacific Newborn Screening Market Forecast, by Country/Sub-region
12.3.1. Japan
12.3.2. China
12.3.3. India
12.3.4. South Korea
12.3.5. Rest of Asia Pacific
12.4. Asia Pacific Newborn Screening Market Value Share and Attractiveness Analysis, by Product
12.5. Asia Pacific Newborn Screening Market Forecast, by Product
12.5.1. Instruments
12.5.1.1. Tabletop
12.5.1.2. Point-of-Care Testing
12.5.2. Assay Kits
12.6. Asia Pacific Newborn Screening Market Value Share and Attractiveness Analysis, by Test Type
12.7. Asia Pacific Newborn Screening Market Forecast, by Test Type
12.7.1. Dry Blood Spot Test
12.7.2. Hearing Screen Test
12.7.3. Critical Congenital Heart Disease (CCHD) Test
12.7.4. X-ray or CT Scan
12.7.5. Electrocardiogram (ECG) Test
12.7.6. Others
12.8. Asia Pacific Newborn Screening Market Value Share and Attractiveness Analysis, by End-user
12.9. Asia Pacific Newborn Screening Market Forecast, by End-user
12.9.1. Hospitals
12.9.2. Diagnostic Centers
12.9.3. Maternity & Specialty Clinics
12.9.4. Others
13. Latin America Newborn Screening Market Analysis
13.1. Latin America Newborn Screening Market Overview
13.2. Latin America Newborn Screening Market Value Share and Attractiveness Analysis, by Country/Sub-region
13.3. Latin America Newborn Screening Market Forecast, by Country/Sub-region
13.3.1. Brazil
13.3.2. Mexico
13.3.3. Rest of Latin America
13.4. Latin America Newborn Screening Market Value Share and Attractiveness Analysis, by Product
13.5. Latin America Newborn Screening Market Forecast, by Product
13.5.1. Instruments
13.5.1.1. Tabletop
13.5.1.2. Point-of-Care Testing
13.5.2. Assay Kits
13.6. Latin America Newborn Screening Market Value Share and Attractiveness Analysis, by Test Type
13.7. Latin America Newborn Screening Market Forecast, by Test Type
13.7.1. Dry Blood Spot Test
13.7.2. Hearing Screen Test
13.7.3. Critical Congenital Heart Disease (CCHD) Test
13.7.4. X-ray or CT Scan
13.7.5. Electrocardiogram (ECG) Test
13.7.6. Others
13.8. Latin America Newborn Screening Market Value Share and Attractiveness Analysis, by End-user
13.9. Latin America Newborn Screening Market Forecast, by End-user
13.9.1. Hospitals
13.9.2. Diagnostic Centers
13.9.3. Maternity & Specialty Clinics
13.9.4. Others
14. Middle East & Africa Newborn Screening Market Analysis
14.1. Middle East & Africa Newborn Screening Market Overview
14.2. Middle East & Africa Newborn Screening Market Value Share and Attractiveness Analysis, by Country/Sub-region
14.3. Middle East & Africa Newborn Screening Market Forecast, by Country/Sub-region
14.3.1. GCC Countries
14.3.2. South Africa
14.3.3. Rest of Middle East & Africa
14.4. Middle East & Africa Newborn Screening Market Value Share and Attractiveness Analysis, by Product
14.5. Middle East & Africa Newborn Screening Market Forecast, by Product
14.5.1. Instruments
14.5.2. Tabletop
14.5.3. Point-of-Care Testing
14.5.4. Assay Kits
14.6. Middle East & Africa Newborn Screening Market Value Share and Attractiveness Analysis, by Test Type
14.7. Middle East & Africa Newborn Screening Market Forecast, by Test Type
14.7.1. Dry Blood Spot Test
14.7.2. Hearing Screen Test
14.7.3. Critical Congenital Heart Disease (CCHD) Test
14.7.4. X-ray or CT Scan
14.7.5. Electrocardiogram (ECG) Test
14.7.6. Others
14.8. Middle East & Africa Newborn Screening Market Value Share and Attractiveness Analysis, by End-user
14.9. Middle East & Africa Newborn Screening Market Forecast, by End-user
14.9.1. Hospitals
14.9.2. Diagnostic Centers
14.9.3. Maternity & Specialty Clinics
14.9.4. Others
15. Competition Landscape
15.1. Competition Matrix
15.2. Company Share Analysis, 2019
15.3. Company Profiles
15.3.1. PerkinElmer, Inc.
15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.1.2. Financial Overview
15.3.1.3. Product Portfolio
15.3.1.4. SWOT Analysis
15.3.1.5. Strategic Overview
15.3.2. Trivitron Healthcare
15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.2.2. Product Portfolio
15.3.2.3. SWOT Analysis
15.3.2.4. Strategic Overview
15.3.3. Natus Medical Incorporated
15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.3.2. Financial Overview
15.3.3.3. Product Portfolio
15.3.3.4. SWOT Analysis
15.3.3.5. Strategic Overview
15.3.4. Medtronic plc
15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.4.2. Financial Overview
15.3.4.3. Product Portfolio
15.3.4.4. SWOT Analysis
15.3.4.5. Strategic Overview
15.3.5. Thermo Fisher Scientific, Inc.
15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.5.2. Financial Overview
15.3.5.3. Product Portfolio
15.3.5.4. SWOT Analysis
15.3.5.5. Strategic Overview
15.3.6. Bio-Rad Laboratories, Inc.
15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.6.2. Financial Overview
15.3.6.3. Product Portfolio
15.3.6.4. SWOT Analysis
15.3.6.5. Strategic Overview
15.3.7. GE Healthcare (General Electric Company)
15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.7.2. Financial Overview
15.3.7.3. Product Portfolio
15.3.7.4. SWOT Analysis
15.3.7.5. Strategic Overview
15.3.8. ZenTech S.A.
15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.8.2. Product Portfolio
15.3.8.3. SWOT Analysis
15.3.8.4. Strategic Overview
15.3.9. MP BIOMEDICALS
15.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.9.2. Product Portfolio
15.3.9.3. SWOT Analysis
15.3.9.4. Strategic Overview
15.3.10. Baebies, Inc.
15.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.10.2. Product Portfolio
15.3.10.3. SWOT Analysis
15.3.10.4. Strategic Overview
15.3.11. Masimo
15.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.11.2. Financial Overview
15.3.11.3. Product Portfolio
15.3.11.4. SWOT Analysis
15.3.11.5. Strategic Overview